Clinical Trial Update: Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study [Phase 2]

View source ↗

Summary

This Phase 2 pilot study evaluated the efficacy and safety of risedronate (Actonel) in patients with ankylosing spondylitis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Actonel (risedronate)

Snippet

Sponsor: University of Zurich | Conditions: Ankylosing Spondylitis | Phase 2 | Status: COMPLETED